CN Patent

CN115484992A — 药物制剂

Assigned to Landy Diagnostics Co ltd · Expires 2022-12-16 · 3y expired

What this patent protects

本发明涉及一种药物组合物，其包含含有氟化硅和螯合基团的放射性杂合剂，其中或者所述氟是 18 F，或者所述螯合基团含有螯合的放射性金属，其中所述组合物具有4.0‑6.0的pH并且还包含：0.1‑200mM柠檬酸盐缓冲液；1‑100mg/mL乙醇；和5‑10mg/mL氯化钠。

USPTO Abstract

本发明涉及一种药物组合物，其包含含有氟化硅和螯合基团的放射性杂合剂，其中或者所述氟是 18 F，或者所述螯合基团含有螯合的放射性金属，其中所述组合物具有4.0‑6.0的pH并且还包含：0.1‑200mM柠檬酸盐缓冲液；1‑100mg/mL乙醇；和5‑10mg/mL氯化钠。

Drugs covered by this patent

Patent Metadata

Patent number
CN115484992A
Jurisdiction
CN
Classification
—
Expires
2022-12-16
Drug substance claim
No
Drug product claim
No
Assignee
Landy Diagnostics Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.